Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03094806 · ClinicalTrials.gov registry record · NA

Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPD

A NA study of Chronic Obstructive Pulmonary Disease, sponsored by New York Presbyterian Brooklyn Methodist Hospital.

Completed
Registry status
NA
Development phase
91
Enrollment target
1
Study location

NCT03094806 is a NA study of Chronic Obstructive Pulmonary Disease that has completed, run by New York Presbyterian Brooklyn Methodist Hospital. The registered enrollment target is 91 participants, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03094806, a NA study of Chronic Obstructive Pulmonary Disease, has completed, sponsored by New York Presbyterian Brooklyn Methodist Hospital.

COMPLETED
Registry status
NA
Development phase
91 participants
Enrollment target
1
Study location

Study Summary

This study is evaluating the use of a respiratory device, the Acapella Vibratory Positive Expiratory Pressure (PEP) Therapy device, in patients admitted to the hospital with a chronic obstructive pulmonary disease (COPD) exacerbation.

Interventions

  • DEVICE Acapella Vibratory PEP Therapy Device plus usual care
  • DEVICE Sham Acapella Vibratory PEP Device plus usual care

Study Locations (1)

New York

  • New York Methodist Hospital - Brooklyn

Trial Details

FieldValue
Enrollment Target 91 participants
Start Date 2013-10
Est. Completion 2015-12
Phase NA

What the Registry Record Tells You About NCT03094806

The ClinicalTrials.gov registry entry for NCT03094806 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 91 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,753-participant average among 86 other Chronic Obstructive Pulmonary Disease trials with a reported enrollment target (95% lower). The listed sponsor is New York Presbyterian Brooklyn Methodist Hospital, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Obstructive Pulmonary Disease appearing as the primary indexed condition, and to 2 interventions - of which Acapella Vibratory PEP Therapy Device plus usual care is the first listed.

NCT03094806 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT03094806 about?

NCT03094806 is a clinical study titled "Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPD". This study is evaluating the use of a respiratory device, the Acapella Vibratory Positive Expiratory Pressure (PEP) Therapy device, in patients admitted to the hospital with a chronic obstructive pulmonary disease (COPD) exacerbation.

What is the current status of trial NCT03094806?

This trial is currently completed. It is a NA study. The enrollment target is 91 participants. The study started on 2013-10. Estimated completion is 2015-12.

What conditions does trial NCT03094806 study?

This clinical trial studies the following conditions: Chronic Obstructive Pulmonary Disease.

What interventions are being tested in trial NCT03094806?

The interventions under investigation include: Acapella Vibratory PEP Therapy Device plus usual care (DEVICE), Sham Acapella Vibratory PEP Device plus usual care (DEVICE).

Who is sponsoring clinical trial NCT03094806?

This trial is sponsored by New York Presbyterian Brooklyn Methodist Hospital, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03094806 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Obstructive Pulmonary Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.